Medicine and Dentistry
Peroxisome Proliferator Activated Receptor
100%
Diabetes Mellitus
41%
Diabetic Nephropathy
33%
Glucose
16%
Immunohistochemistry
16%
Triacylglycerol
16%
Leukocyte
16%
Nephropathy
16%
Fatty Acid
16%
Hyperglycemia
16%
Collagen Type 4
16%
Peroxisome Proliferator Activated Receptor Agonist
16%
Mesangial Cell
16%
Serum
8%
Fibrinogen
8%
Pathogenesis
8%
Serositis
8%
In Vitro
8%
Programmed Cell Death
8%
Low Drug Dose
8%
Lipid Metabolism
8%
Therapeutic Agent
8%
Ligand
8%
Extracellular Matrix
8%
Cell Nucleus Receptor
8%
Glomerulosclerosis
8%
Osteopontin
8%
Hemoglobin A1c
8%
Streptozocin
8%
Fenofibrate
8%
Albuminuria
8%
Glucose Homeostasis
8%
Male
8%
Kidney
8%
Macrophage
8%
Blood
8%
Transforming Growth Factor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Wild Type Mouse
58%
Diabetes Mellitus
50%
Diabetic Nephropathy
33%
Kidney Disease
16%
Glucose
16%
Hyperglycemia
16%
Fatty Acid
16%
Knockout Mouse
16%
Triacylglycerol
16%
PPAR Agonist
16%
Collagen Type 4
16%
Ligand
8%
Cell Nucleus Receptor
8%
Glomerulosclerosis
8%
Pathogenesis
8%
Osteopontin
8%
Streptozotocin
8%
Fibrinogen
8%
Hemoglobin A1c
8%
Fenofibrate
8%
Albuminuria
8%
Mouse
8%
Transforming Growth Factor
8%